{"id":"https://openalex.org/W4361845985","doi":"https://doi.org/10.1158/0008-5472.c.6510956","title":"Data from IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma","display_name":"Data from IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361845985","doi":"https://doi.org/10.1158/0008-5472.c.6510956"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6510956","doi":"https://doi.org/10.1158/0008-5472.c.6510956","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6510956","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6510956","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051072518","display_name":"Phyllis S.Y. Chong","orcid":"https://orcid.org/0000-0001-7546-3411","observed_orcids":["https://orcid.org/0000-0001-7546-3411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phyllis S.Y. Chong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045967361","display_name":"Jianbiao Zhou","orcid":"https://orcid.org/0000-0002-5679-671X","observed_orcids":["https://orcid.org/0000-0002-5679-671X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianbiao Zhou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5679-671X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090253810","display_name":"Julia S.L. Lim","orcid":"https://orcid.org/0000-0002-4561-1679","observed_orcids":["https://orcid.org/0000-0002-4561-1679"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia S.L. Lim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030928202","display_name":"Yan Ting Hee","orcid":"https://orcid.org/0000-0002-8530-8957","observed_orcids":["https://orcid.org/0000-0002-8530-8957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Ting Hee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057555967","display_name":"Jing-Yuan Chooi","orcid":"https://orcid.org/0009-0004-6438-7555","observed_orcids":["https://orcid.org/0009-0004-6438-7555"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing-Yuan Chooi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038484393","display_name":"Tae\u2010Hoon Chung","orcid":"https://orcid.org/0000-0003-1737-6322","observed_orcids":["https://orcid.org/0000-0003-1737-6322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tae-Hoon Chung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011071358","display_name":"Zea Tuan Tan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zea Tuan Tan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112309547","display_name":"Qi Zeng","orcid":"https://orcid.org/0009-0008-1496-5731","observed_orcids":["https://orcid.org/0009-0008-1496-5731"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Zeng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031061959","display_name":"Daniel Dirck Waller","orcid":"https://orcid.org/0000-0002-8291-2630","observed_orcids":["https://orcid.org/0000-0002-8291-2630"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel D. Waller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064552806","display_name":"Micha\u00ebl S\u00e9bag","orcid":"https://orcid.org/0000-0002-9013-2941","observed_orcids":["https://orcid.org/0000-0002-9013-2941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Sebag","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5066282840","display_name":"Wee Joo Chng","orcid":"https://orcid.org/0000-0003-2578-8335","observed_orcids":["https://orcid.org/0000-0003-2578-8335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wee-Joo Chng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.6586999893188477,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.6586999893188477,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.3156999945640564,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/prl-3","display_name":"PRL-3","score":0.8410000205039978},{"id":"https://openalex.org/keywords/stat3","display_name":"STAT3","score":0.8080000281333923},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.6690000295639038},{"id":"https://openalex.org/keywords/shp2","display_name":"SHP2","score":0.972000002861023},{"id":"https://openalex.org/keywords/feedforward-loop","display_name":"feed-forward loop","score":0.9120000004768372},{"id":"https://openalex.org/keywords/gp130","display_name":"gp130","score":0.7450000047683716},{"id":"https://openalex.org/keywords/bortezomib-resistance","display_name":"bortezomib resistance","score":0.9409999847412109},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.6079999804496765},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9940000176429749},{"id":"https://openalex.org/keywords/antiapoptotic-genes","display_name":"anti-apoptotic genes","score":0.8389999866485596},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8859999775886536},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5400000214576721},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7200000286102295},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7143926620483398},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6579493284225464},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6547282934188843},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.6236605048179626},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.5305402874946594},{"id":"https://openalex.org/C186310378","wikidata":"https://www.wikidata.org/wiki/Q941796","display_name":"Psychological repression","level":4,"score":0.5178371071815491},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.48246103525161743},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4515126049518585},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.42162835597991943},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35326650738716125},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.33468562364578247},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.27788251638412476},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.23525264859199524},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20510613918304443},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1695961058139801},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12052834033966064}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6510956","doi":"https://doi.org/10.1158/0008-5472.c.6510956","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6510956","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6510956","doi":"https://doi.org/10.1158/0008-5472.c.6510956","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6510956","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2963854884","https://openalex.org/W2969290870","https://openalex.org/W4361845824","https://openalex.org/W2325862385","https://openalex.org/W3080214952","https://openalex.org/W2586279587","https://openalex.org/W2245698905","https://openalex.org/W2487449221","https://openalex.org/W107349270","https://openalex.org/W3183267314"],"abstract_inverted_index":{"Abstract":[0],"Overexpression":[1],"of":[2,26,48,51,69,77,81,96,109,115,124,145,256],"PRL-3,":[3,257],"an":[4],"oncogenic":[5,24],"phosphatase,":[6],"was":[7,164,176],"identified":[8],"as":[9,43,100,190,242],"a":[10,44,61,139,191,224,243],"novel":[11,211],"cluster":[12],"in":[13,28,60,141,167,179,235,247,259,273],"patients":[14,180,196],"with":[15,181,197,210],"newly":[16],"diagnosed":[17],"multiple":[18,29,198,236,248,274],"myeloma.":[19,249,275],"However,":[20],"the":[21,73,122,142,172],"regulation":[22],"and":[23,57,67,88,90,105,117,128,130,134,161,171,204,216,229,238,263],"activities":[25],"PRL-3":[27,52,82,110,136,155,162,183,186,230,241],"myeloma":[30,54,84,146,199],"warrant":[31],"further":[32],"investigation.":[33],"Here,":[34],"we":[35],"report":[36],"that":[37,200,231],"IL6":[38,251],"activates":[39,265],"STAT3,":[40],"which":[41,150,258],"acts":[42],"direct":[45,65],"transcriptional":[46,254],"regulator":[47],"PRL-3.":[49],"Upregulation":[50],"increased":[53],"cell":[55,85],"viability":[56],"rephosphorylated":[58],"STAT3":[59,78,116,160,173,228,262,266],"biphasic":[62],"manner":[63],"through":[64],"interaction":[66],"deactivation":[68],"SHP2,":[70],"thus":[71],"blocking":[72],"gp130":[74],"(Y759)-mediated":[75],"repression":[76],"activity.":[79],"Abrogation":[80],"reduced":[83,118],"survival,":[86],"clonogenicity,":[87],"tumorigenesis,":[89],"detailed":[91],"mechanistic":[92],"studies":[93],"revealed":[94],"\u201cdeactivation\u201d":[95],"effector":[97],"proteins":[98],"such":[99],"Akt,":[101],"Erk1/2,":[102],"Src,":[103],"STAT1,":[104],"STAT3.":[106],"Furthermore,":[107,185],"loss":[108],"efficiently":[111],"abolished":[112],"nuclear":[113],"localization":[114],"its":[119],"occupancy":[120],"on":[121],"promoter":[123],"target":[125,267],"genes":[126,132],"c-Myc":[127],"Mcl-1,":[129],"antiapoptotic":[131],"Bcl2":[133],"Bcl-xL.":[135],"also":[137],"played":[138],"role":[140],"acquired":[143],"resistance":[144,272],"cells":[147],"to":[148,193,270],"bortezomib,":[149],"could":[151,187],"be":[152,188],"overcome":[153],"by":[154],"silencing.":[156],"Of":[157],"clinical":[158],"relevance,":[159],"expression":[163],"positively":[165],"correlated":[166],"five":[168],"independent":[169],"cohorts,":[170],"activation":[174],"signature":[175],"significantly":[177],"enriched":[178],"high":[182],"expression.":[184],"used":[189],"biomarker":[192],"identify":[194],"high-risk":[195],"exhibited":[201],"poor":[202],"prognosis":[203],"inferior":[205],"outcome":[206],"even":[207],"when":[208],"treated":[209],"combinational":[212],"therapeutics":[213],"(proteasome":[214],"inhibitors":[215],"immunomodulatory":[217],"imide":[218],"drugs).":[219],"Conclusively,":[220],"our":[221],"results":[222],"support":[223],"feedforward":[225],"mechanism":[226],"between":[227],"prolongs":[232],"prosurvival":[233],"signaling":[234],"myeloma,":[237],"suggest":[239],"targeting":[240],"valid":[244],"therapeutic":[245],"opportunity":[246],"Significance:":[250],"promotes":[252],"STAT3-dependent":[253],"upregulation":[255],"turn":[260],"re-phosphorylates":[261],"aberrantly":[264],"genes,":[268],"leading":[269],"bortezomib":[271]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}